Cargando…
Hypoplastic acute myeloid leukemia in an elderly patient. A long‐term partial remission with low‐dose prednisone and G‐CSF
Hypoplastic acute myeloid leukemia (AML) is a rare variant of AML that mainly affects the elderly and accounts for 5%‐7% of de novo AML. Prognosis for this disease is poor, and there is no standard therapy. We have treated an elderly patient with hypoplastic AML with low‐dose prednisone and G‐CSF wi...
Autor principal: | Islam, Anwarul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637338/ https://www.ncbi.nlm.nih.gov/pubmed/31360468 http://dx.doi.org/10.1002/ccr3.2204 |
Ejemplares similares
-
Higher‐risk myelodysplastic syndrome in an elderly patient: Long‐term partial remission with low‐dose prednisone, G‐CSF, and epoetin alfa
por: Islam, Anwarul
Publicado: (2021) -
Induction treatment of acute myeloid leukemia in an elderly patient with intramarrow injection/administration of cytarabine. Second case report
por: Islam, Anwarul
Publicado: (2017) -
Induction treatment of acute myeloid leukemia in an elderly patient with intramarrow injection/administration of cytarabine: first report of a case
por: Islam, Anwarul
Publicado: (2015) -
Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia
por: Li, Jianyong, et al.
Publicado: (2015) -
MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF
por: Wang, Xin, et al.
Publicado: (2021)